Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Verweij

Showing results (91-100 of 234) with videos related to

Pageof 24
Sort By:
Investigational New Drugs|October 28, 2003
Effect of valspodar on the pharmacokinetics of unbound paclitaxelAlbert J ten Tije, Timothy W Synold, Darcy Spicer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinibPaul Hamberg, Floris A de Jong, Joke G Boonstra, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2010
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cellsNadine Pouw, Elike Treffers-Westerlaken, Jaco Kraan, et al.
Cancer Biology & Therapy|September 14, 2006
Hepatic transport, metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drainFloris A de Jong, Jos J E M Kitzen, Peter de Bruijn, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Influence of ketoconazole on the fecal and urinary disposition of docetaxelFrederike K Engels, Walter J Loos, Ron A A Mathot, et al.
Cancer Biology & Therapy|June 16, 2006
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxelFrederike K Engels, Ron A A Mathot, Walter J Loos, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 22, 2011
Drug transporters of platinum-based anticancer agents and their clinical significanceHerman Burger, Walter J Loos, Karel Eechoute, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2013
Modifying phase I methodology to facilitate enrolment of molecularly selected patientsAntoine Hollebecque, Sophie Postel-Vinay, Jaap Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Impact of body-size measures on irinotecan clearance: alternative dosing recommendationsRon H J Mathijssen, Jaap Verweij, Maja J A de Jonge, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 1, 2002
Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatographyWalter J Loos, Desirée M van Zomeren, Hans Gelderblom, et al.
Pageof 24

Showing results (91-100 of 234) with videos related to

Sort By:
Pageof 24
Investigational New Drugs|October 28, 2003
Effect of valspodar on the pharmacokinetics of unbound paclitaxelAlbert J ten Tije, Timothy W Synold, Darcy Spicer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinibPaul Hamberg, Floris A de Jong, Joke G Boonstra, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2010
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cellsNadine Pouw, Elike Treffers-Westerlaken, Jaco Kraan, et al.
Cancer Biology & Therapy|September 14, 2006
Hepatic transport, metabolism and biliary excretion of irinotecan in a cancer patient with an external bile drainFloris A de Jong, Jos J E M Kitzen, Peter de Bruijn, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2007
Influence of ketoconazole on the fecal and urinary disposition of docetaxelFrederike K Engels, Walter J Loos, Ron A A Mathot, et al.
Cancer Biology & Therapy|June 16, 2006
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxelFrederike K Engels, Ron A A Mathot, Walter J Loos, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 22, 2011
Drug transporters of platinum-based anticancer agents and their clinical significanceHerman Burger, Walter J Loos, Karel Eechoute, et al.
European Journal of Cancer (Oxford, England : 1990)|January 22, 2013
Modifying phase I methodology to facilitate enrolment of molecularly selected patientsAntoine Hollebecque, Sophie Postel-Vinay, Jaap Verweij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Impact of body-size measures on irinotecan clearance: alternative dosing recommendationsRon H J Mathijssen, Jaap Verweij, Maja J A de Jonge, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|February 1, 2002
Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatographyWalter J Loos, Desirée M van Zomeren, Hans Gelderblom, et al.
Pageof 24